Technology

SpringWorks

$85.29
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

$0.00 (0.00%) As of 2:34 PM UTC today

Why Robinhood?

You can buy or sell SpringWorks and other stocks, options, and ETFs commission-free!

About SWTX

SpringWorks Therapeutics, Inc. Common Stock, also called SpringWorks, is a clinical-stage biopharmaceutical company, which engages in applying a precision medicine approach to acquiring, developing and commercializing medicines. It focuses on developing drugs for underserved patient populations suffering from devastating rare diseases and cancer. Its pipeline include Nirogacestat, Mirdametinib and BGB-3245. The company was founded in August 2017 and is headquartered in Stamford, CT. The listed name for SWTX is SpringWorks Therapeutics, Inc. Common Stock.

CEO
Saqib Islam
Employees
56
Headquarters
Stamford, Connecticut
Founded
2017
Market Cap
3.85B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
457.89K
High Today
$86.72
Low Today
$85.30
Open Price
$85.57
Volume
8.23K
52 Week High
$87.60
52 Week Low
$19.50

Collections

SWTX Earnings

-$1.77
-$1.18
-$0.59
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Mar 11, Pre-Market

You May Also Like

XOMA
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure